DAIC

DECEMBER 26, 2023

reported results from a clinical study of revolutionary earbuds that use a new technology - In-ear Infrasonic Hemodynography to Detects Aortic Stenosis Murmur Before and After Transcatheter Aortic Valve Replacement (TAVR). We propose a new method of assessing aortic stenosis through IH to detect its characteristic systolic ejection murmur."

Stenosis 59

Stenosis Technology Aortic Aortic valve 59

DAIC

APRIL 1, 2024

“The concepts I wrote in this paper also form the crux of what we are doing here at the Center for Innovation at Robert Wood Johnson University Hospital, an RWJBarnabas Health facility. Is There Medication for Valvular Heart Disease?

Technology 105

Technology Heart Disease Innovation Ultrasound 105

DAIC

FEBRUARY 3, 2025

Roche has an unrivaled ability to provide access to testing at scale and is committed to advancing innovation in preventive cardiology. For more information, please visit www.roche.com. Tsimikas S and Marcovina S, Ancestry, Lipoprotein(a), and Cardiovascular Risk Thresholds: JACC Review Topic of the Week , J Am Coll Cardiol.

Cardiovascular Disease 52

Cardiovascular Disease Aortic valve Biomarkers Innovation 52

DAIC

JANUARY 9, 2024

Through its AI capability, Cleerly ISCHEMIA determines the likely presence or absence of coronary vessel ischemia based on quantitative measures of atherosclerosis, stenosis, and significant vascular morphology from patients’ CCTA images. We are proud to support healthcare professionals personalize patients' heart health journeys.

Ischemia 119

Ischemia Heart Disease Coronary Artery Disease Atherosclerosis 119

DAIC

MAY 1, 2024

The Society for Cardiovascular Angiography & Interventions (SCAI) kicks off its SCAI Scientific Sessions 2024 this week, May 2-4 in Long Beach, CA, bringing together more than 1,800 clinicians, scientists, researchers, and innovators in the field of interventional cardiology and endovascular medicine.

Interventional Cardiology 105

Interventional Cardiology Aortic valve TAVR Peripheral Arterial Disease 105

ADN Center of Excellence

DECEMBER 4, 2023

Addressing calcification-induced stenosis and regurgitation necessitates innovative solutions. Bridging the Gap in Elderly Care The escalating prevalence of mitral annular calcification among the elderly poses distinct challenges.

Bicuspid/Mitral 52

Bicuspid/Mitral Innovation Interventional Cardiology Stenosis 52

DAIC

JUNE 4, 2024

The Neuroguard Integrated Embolic Protection (IEP) system is an experimental treatment for carotid artery stenosis, also known as carotid artery disease, a condition in which fatty-waxy deposits known as plaque builds up and blocks the normal flow of blood in the large arteries on either side of the neck. Designed by Raleigh, N.C.

Stents 111

Stents Stent Research Stroke 111

DAIC

JANUARY 17, 2024

At present, machine learning, deep learning, and other AI technologies have been tried to be applied to intelligent diagnostic and decision making, image interpretation, accurate classification, and prognostication of cardiovascular diseases, which has led to broad application prospects and innovation potential.

Technology 111

Technology Coronary Artery Disease Cardiovascular Disease Cardiovascular Imaging 111

DAIC

MARCH 6, 2024

The CAD Staging System is a noninvasive imaging-based investigational software device that analyzes important and actionable features of coronary atherosclerosis, stenosis and ischemia. Cleerly’s mission extends beyond innovation; it is a commitment to saving lives by revolutionizing the prevention and treatment of heart disease.

Heart Disease 105

Heart Disease Heart Attack Heart attacks Technology 105

DAIC

JANUARY 4, 2024

In all cases, patients achieved complete resolution of aortic disease with no residual stenosis or regurgitation immediately following the procedure, and all patients were discharged within 24-48 hours of the procedure.

Aortic valve 105

Aortic valve Heart Valves Aortic Technology 105

ADN Center of Excellence

DECEMBER 4, 2023

Addressing calcification-induced stenosis and regurgitation necessitates innovative solutions. Bridging the Gap in Elderly Care The escalating prevalence of mitral annular calcification among the elderly poses distinct challenges.

Bicuspid/Mitral 40

Bicuspid/Mitral Innovation Interventional Cardiology Stenosis 40

DAIC

MAY 8, 2024

6 This novel study marks a significant milestone in the field, evaluating the effectiveness of FFR CT in detecting ischemia-producing coronary stenosis in patients with severe PAD. Journal of Vascular Surgery Cases, Innovations and Techniques, vol. 101272, [link].

Coronary Artery Disease 111

Coronary Artery Disease Chest Pain Ischemia Myocardial Infarction 111

DAIC

JUNE 7, 2024

The CoreValve and next-generation Evolut TAVR systems are used in TAVR procedures for patients with symptomatic severe aortic stenosis (AS), which are less invasive and typically result in a quicker recovery time than open heart surgery.i The natural history and rate of progression of aortic stenosis. iii Am Heart Assoc. 120.018816.

TAVR 111

TAVR Aortic valve Aortic Stenosis 111

DAIC

MAY 18, 2024

At 3 and 6 months after ablation in patients with paroxysmal and non-paroxysmal AF, researchers did not observe any reported deaths or certain serious complications, including coronary spasm, persistent phrenic nerve palsy, atrio-esophageal fistula, or pulmonary vein stenosis. Lucas Boersma , electrophysiologist, St.

Heart Rhythm 105

Heart Rhythm Atrial Fibrillation Ablation Quality of Life 105

DAIC

FEBRUARY 13, 2024

Previous to GWU, Earls served as Medical Director and Vice President at Fairfax Radiological Consultants (FRC) in Fairfax, VA, where he was an early innovator and clinical adopter of coronary CT angiography. Journal of Cardiovascular Computed Tomography Vol. AJR Am J Roentgenol 2022 Sep;219(3):407-419. 7 Bär S, Nabeta T, Maaniitty T.

Coronary Artery Disease 103

Coronary Artery Disease Ischemia Atherosclerosis Cardiovascular Imaging 103

DAIC

MARCH 28, 2024

Based on the results from the admIRE clinical trial, we are confident that this innovation has the promise to deliver significant value and differentiated capabilities, and become an important tool for the treatment of AFib." patients, were presented as a late-breaker at the 2024 AF Symposium.

Atrial Fibrillation 110

Atrial Fibrillation AFIB Ablation Pulmonary 110

DAIC

JUNE 18, 2024

However, the data with the ‘leave nothing behind’ approach with bioresorbable scaffold technologies, showed non-plateauing event rates continue to occur even after resorption of the scaffold, so we needed a more innovative approach to restore vessel viability,” said Motasim Sirhan, CEO of Elixir Medical.

Coronary Artery Disease 105

Coronary Artery Disease Technology Stents Stent 105

DAIC

MAY 30, 2024

stenosis in the target lesion. The features of this device illustrate our commitment to innovation, and now we have evidence to support the utility of this design.” At baseline, 12.5% of enrolled patients had critical limb ischemia, 90% had calcified lesions (30.7% severe calcification), and there was an average of 85.5%

Stents 69

Stents Stent Peripheral Arterial Disease Innovation 69

Stroke: Vascular and Interventional Neurology

AUGUST 4, 2024

BackgroundCarotid endarterectomy (CEA) is an established procedure for the treatment of extracranial internal carotid artery stenosis. Research was funded by Germany's Federal Joint Committee Innovation Fund (funding reference number 01VSF19016). Stroke: Vascular and Interventional Neurology, Volume 4, Issue 6 , November 1, 2024.

Hospital 40

Hospital Outcomes Myocardial Infarction Stenosis 40

Circulation

JANUARY 15, 2024

Limited spatial resolution and blooming artifacts may hinder estimation of degree of coronary artery stenosis. These innovations may speed achieving the ultimate goal of providing noninvasively specific and clinically actionable information.

Coronary Artery Disease 45

Coronary Artery Disease Atherosclerosis Laboratory Plaque 45

Open Heart

JULY 10, 2023

The risk of AF was estimated using the FIND-AF (Future Innovations in Novel Detection of Atrial Fibrillation) risk score. to 6.85; 4.54), aortic stenosis (18.7; Methods From the UK Clinical Practice Research Datalink-GOLD dataset, 2 January 1998–30 November 2018, we identified individuals aged ≥30 years without known AF.

Atrial Fibrillation 52

Atrial Fibrillation Myocardial Infarction Kidney Disease Innovation 52

Cassling

MAY 25, 2023

The Midwest company will begin offering EchoSolv, an artificial intelligence clinical decision support platform designed to help detect severe aortic stenosis, to providers throughout the country. Omaha, Neb. –

Stenosis 52

Stenosis Aortic Innovation Blog 52

DAIC

FEBRUARY 2, 2024

As Biosense Webster advances innovation for the treatment of AFib, we are thinking not only about new modalities of ablation, such as pulsed field ablation, but also how to make procedures safer, more effective and efficient. 1 These included one pseudoaneurysm, one PV stenosis and one hematoma.1

Ablation 105

Ablation Atrial Fibrillation AFIB Heart Rhythm 105

Dr. S. Venkatesan MD

SEPTEMBER 23, 2024

Likelihood of truth : High The flamboyant genius of Andreas Roland Gruntzig, from Zurich gifted us the path-breaking treatment modality for coronary stenosis five decades ago. ORBITA-1 was an excellent and Innovative trial, that answered the above query without any doubt , that PCI has no add on value over medical therapy in chronic CAD.

Angina 52

Angina Academic Stenosis Article 52

Stroke Journal

FEBRUARY 1, 2024

Innovative solutions, such as Vascular Endothelial Growth Factor (VEGF)-infused hydrogel biomaterials, have emerged. Stroke, Volume 55, Issue Suppl_1 , Page A154-A154, February 1, 2024. Introduction:Cerebrovascular ischemia poses a substantial neurological threat due to cerebral artery constriction.

Ischemia 40

Ischemia Innovation Stenosis Stroke 40

Wellnest

JANUARY 24, 2024

This innovative technique not only provides functional heart valves for neonates but also offers the promise of lifelong solutions, transforming the landscape of pediatric heart surgeries.

Heart Transplant 52

Heart Transplant Transplant Pediatrics Congenital 52

Dr. S. Venkatesan MD

JUNE 16, 2024

We must thank the technological innovators in the electro-anatomical mapping system, who are continuously upgrading and providing the best to us. This is what DC shocks do for temporary reversion to sinus rhythm ) How to localize the diastolic pathways ? How can we remember this EP lesson easily ?

Ablation 52

Ablation Physiology Technology Bicuspid/Mitral 52

DAIC

APRIL 5, 2024

Our goal is to unite specialists from every corner of cardiovascular care to extend the heart team, redefine innovations, and develop new standards for managing valve patients." Transcatheter valve therapy has evolved from a novel treatment for the sickest patients to become the standard of care for many with aortic stenosis.

Research 52

Research Heart Disease Best Practices Education 52

DAIC

APRIL 5, 2024

Our goal is to unite specialists from every corner of cardiovascular care to extend the heart team, redefine innovations, and develop new standards for managing valve patients." Transcatheter valve therapy has evolved from a novel treatment for the sickest patients to become the standard of care for many with aortic stenosis.

Heart Disease 52

Heart Disease Best Practices Education Tricuspid 52

DAIC

JANUARY 22, 2024

These are true innovators who propose novel approaches to major research challenges in the areas of heart disease, stroke and brain health. Blood lipids such as cholesterol and triglycerides are causal risk factors for coronary heart disease as well as several other types of cardiovascular disease , such as aortic stenosis).

Heart Disease 105

Heart Disease Research Aneurysm Cardiovascular Disease 105

DAIC

FEBRUARY 29, 2024

24: Joint American College of Cardiology/Journal of the American College of Cardiology Late-Breaking Clinical Trials (Session 402) Saturday, April 6 9:30 – 10:30 a.m.

Aortic valve 103

Aortic valve Myocardial Infarction Aortic Blood Pressure 103

Dr. S. Venkatesan MD

APRIL 18, 2024

We know a small ASD decompresses mitral stenosis, and the combination of ASD and MS, Lutembacher, is a well-known syndrome called Lutembacher. May be, it will come soon in the innovative lanes of cardiology. The concept of LA flow regulator or decompressor came from this. Probably in the thin membranous area.

Preserved Ejection Fraction 40

Preserved Ejection Fraction Pulmonary Congenital Heart Disease VSD 40

DAIC

APRIL 6, 2024

Raj Makkar, MD , associate director of the Smidt Heart Institute and vice president of Cardiovascular Innovation and Intervention at Cedars-Sinai, will co-chair the session “Flipping the Script: Aortic Stenosis Management in the Modern Era,” Saturday, April 6, 12-1:15 p.m.

Research 105

Research Cardiac Arrest Electrophysiology Chest Pain 105

DAIC

APRIL 2, 2024

In addition to TriClip, the company reports that its innovative, minimally invasive therapies also include first-of-its-kind technologies MitraClip and Amplatzer Piccolo Occluder (to close a hole in the heart of babies), as well as the Navitor transcatheter aortic valve implantation system (to treat aortic stenosis).

Tricuspid 105

Tricuspid Heart Valves Quality of Life Open-Heart Surgery 105

Frontiers in Cardiovascular Medicine

MARCH 5, 2025

This implementation of novel and successful interventional treatment led to the rapid relief of coronary obstruction.DiscussionThis innovative approach offers a promising avenue for further management of these patients in critical conditions.

Aortic valve 52

Aortic valve Aortic Bicuspid/Mitral TAVR 52

Cardiometabolic Health Congress

NOVEMBER 14, 2024

Attendees, including hundreds of health professionals, gained access to the latest knowledge and developments in the field, from exclusive insights from one of the foremost authorities on atherosclerosis, Dr. Peter Libby, to innovations like new therapeutic agents and exciting advancements in renal protection.

CME 103

CME Obesity Heart Failure Biomarkers 103

Cardiometabolic Health Congress

JANUARY 2, 2025

August 2024 Approvals Minima Stent System (P240003) (Approval Date: August 28, 2024) The Minima Stent System is an expandable cobalt-chromium metal mesh tube to reopen blood vessels in neonates, infants, and children with Coarctation of the Aorta and Pulmonary Artery Stenosis, specifically designed to expand as younger patients grow.

Coronary Artery Disease 52

Coronary Artery Disease Stents Stent Innovation 52